1.0MCChttps://www.msd-thailand.com/ensdaochaenghttps://www.msd-thailand.com/en/author/sdaochaeng/COVID-19 - MCCrich600338<blockquote class="wp-embedded-content" data-secret="9ODzDcsKQB"><a href="https://www.msd-thailand.com/en/research/covid-19/">COVID-19</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.msd-thailand.com/en/research/covid-19/embed/#?secret=9ODzDcsKQB" width="600" height="338" title="“COVID-19” — MCC" data-secret="9ODzDcsKQB" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
</script>
Advancing our therapeutic candidate In partnership with Ridgeback Bio, we are moving with urgency to advance the development of an investigational oral antiviral therapeutic. Expanding manufacturing capacity and supply of COVID-19 medicines and vaccines Stepping up as an industry In March 2021, we announced an agreement with BARDA to adapt and make available a number […]